EGLN1 and prostate cancer: To be noted, we did not observe any alteration of HIF1α mRNA levels in DU145 and PC-3 prostate cancer cells overexpressing miR-182 (Fig. 4d), which is consistent with the working model of the regulation of HIF1α by PHD2 and FIH1.